150 mg VISMO Pill: pink gray, capsule/oblong, 19mm
Generic Name: vismodegib
The pill with imprint 150 mg VISMO (Pink / Gray, Capsule/Oblong, 19mm) has been identified as Erivedge 150 mg and is used for Basal Cell Carcinoma. It belongs to the drug class hedgehog pathway inhibitors and is not a controlled substance.
Images for 150 mg VISMO
Erivedge
- Generic Name
- vismodegib
- Imprint
- 150 mg VISMO
- Strength
- 150 mg
- Color
- Pink / Gray
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Hedgehog pathway inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0140
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
sodium lauryl sulfate,
povidone k30,
sodium starch glycolate type A potato,
magnesium silicate,
magnesium stearate,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about Erivedge (vismodegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.